PATENT CLAIM ANALYSIS

Application Number: 15966848
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-09
Patent Classification: ["424", "049000"]

Abstract:
Compositions and methods for the treatment of Charcot-Marie-Tooth disease and related disorders. Also provided are combination therapies for treating this disease by decreasing PMP22 expression in a subject.

Claim (Index 12):
A method for treating Charcot-Marie-Tooth (CMT) disease of type 1 A (CMT1A), comprising administering to a subject in need thereof an effective amount of naltrexone, or a salt or a sustained release formulation thereof.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 91.0
- Lexical Diversity: 1.15385
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12744962', '14269783', '12999125', '15212748', '15390972']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7704189387213178
- 35 USC 102 Novelty (BERT): 0.5965518218226002
- Combined Prediction Score: 0.7530322270314461
- Mean Citation Score: 447.807256
- Max Citation Score: 542.01843
- Similarity Product: 458.73533521667

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test